12 Biggest Mid-Day Gainers For Monday - DDC Enterprise (AMEX:DDC), CytomX Therapeutics (NASDAQ:CTMX)

Esperion Therapeutics Inc ESPR shares climbed 49.3 percent to $35.34 after the company reported the FDA confirmation regarding regulatory pathway to approval for an LDL-C lowering indication for bempedoic acid.
Bellerophon Therapeutics Inc BLPH shares surged 35.4 percent to $1.39.
Nektar Therapeutics NKTR shares jumped 34.2 percent to $20.80 after the company reported that it has achieved primary and secondary endpoints in Phase 3 SUMMIT-07 study.
CytomX Therapeutics Inc CTMX climbed 23.5 percent to $18.74. Bristol-Myers Squibb Co BMY and CytomX Therapeutics disclosed that they have extended worldwide partnership to discover Probody therapeutics for the treatment of cancer and other diseases.
Dominion Diamond Corp DDC shares surged 22.6 percent to $12.16. The Washington Companies proposed to acquire Dominion Diamond for US$13.50 per share in cash.
Aurinia Pharmaceuticals Inc AUPH shares jumped 17.5 percent to $9.05. Aurinia Pharmaceuticals shares have climbed 148.39 percent over the past 52 weeks, while the S&P 500 index has gained 15.92 percent in the same period.
ContraVir Pharmaceuticals Inc CTRV shares gained 16.6 percent to $1.69.
Omeros Corporation OMER shares surged 11.2 percent to $11.72.
FireEye Inc FEYE shares climbed 8.6 percent to $11.65. Bank of America upgraded FireEye from Neutral to Buy.
Aralez Pharmaceuticals Inc ARLZ gained 7.1 percent to $2.41 after the company disclosed that its CEO has purchased 500,000 open market shares at an average price of $2.46 per share.
American Railcar Industries, Inc. ARII rose 7.1 percent to $42.71. Cowen & Co. upgraded American Railcar from Market Perform to Outperform.
MeetMe Inc MEET shares surged 4.8 percent to $5.44. Canaccord Genuity initiated coverage on MeetMe with a Buy rating.

Market News and Data brought to you by Benzinga APIs